Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qilinghuaxian Formula plus NAs vs NAs alone vs NAs plus Fuzhenghuayu in HBV-related liver cirrhosis
ChiCTR2200067068Phase 4Not yet recruiting
- Sponsor
- Ningbo No. 2 Hospital
- Start
- Jan 2023
- Countries
- 1
01
Overview
Phase 4 trial of Qilinghuaxian Formula in hepatitis B-related liver cirrhosis (3 arms), sponsored by Ningbo No. 2 Hospital. Primary endpoints: Serological markers of hepatic fibrosis, Abdominal ultrasound examination and 4 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
Qilinghuaxian Formula
03
Conditions
hepatitis B-related liver cirrhosis
Beyond the preview
Go deeper on ChiCTR2200067068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200067068.